Model averaging in dose-response study in microarray expression
Coughlin_Snack Foods Assn_Acrylamide_June 2011
Heat-Processed Carcinogens: What Can We Learn from the Coffee-Cancer Paradox?_Coughlin_ASIC Naples_October 2013
Coughlin_IFT_NTP Acrylamide_June 14 2011
Reolysin
Nick chen ppt presentation metronomic chemotherapy 2015
Dose-Response Modeling of Gene Expression Data in pre-clinical Microarray Experiments
Pharmacodynamic Paradigms in Early-Phase Cancer Clinical Trials Workshop Phase 0 Trials In Oncologic Drug Development Hilary Calvert Northern Institute.
Oncology Early Clinical Trials’ Designs and their Challenges Pamela N Munster, MD TICR 4-18-2012.
Clinical Trials Jean Bourbeau, MD Respiratory Epidemiology and Clinical Research Unit McGill University Clinical Epidemiology (679) June 17, 2005.
RISK e Learning Computational Toxicology: New Approaches for the 21st Century May 28, 2009 Session 1: Computational Toxicology: An Introduction to Key.
1 FDA Review of DASATINIB Oncology Drug Advisory Committee (ODAC) June 2, 2006.
